127 related articles for article (PubMed ID: 38058256)
41. Osteopontin-dependent CD44v6 expression and cell adhesion in HepG2 cells.
Gao C; Guo H; Downey L; Marroquin C; Wei J; Kuo PC
Carcinogenesis; 2003 Dec; 24(12):1871-8. PubMed ID: 12949055
[TBL] [Abstract][Full Text] [Related]
42. Methods to Investigate Thrombin Cleavage of Osteopontin (OPN).
Zhao L; Leung LL; Morser J
Methods Mol Biol; 2024; 2747():95-117. PubMed ID: 38038935
[TBL] [Abstract][Full Text] [Related]
43. Osteopontin induces growth of metastatic tumors in a preclinical model of non-small lung cancer.
Shojaei F; Scott N; Kang X; Lappin PB; Fitzgerald AA; Karlicek S; Simmons BH; Wu A; Lee JH; Bergqvist S; Kraynov E
J Exp Clin Cancer Res; 2012 Mar; 31(1):26. PubMed ID: 22444159
[TBL] [Abstract][Full Text] [Related]
44. Overexpression of osteopontin and integrin αv in laryngeal and hypopharyngeal carcinomas associated with differentiation and metastasis.
Lu JG; Li Y; Li L; Kan X
J Cancer Res Clin Oncol; 2011 Nov; 137(11):1613-8. PubMed ID: 21853313
[TBL] [Abstract][Full Text] [Related]
45. Interferon-induced transmembrane 3 binds osteopontin in vitro: expressed in vivo IFITM3 reduced OPN expression.
El-Tanani MK; Jin D; Campbell FC; Johnston PG
Oncogene; 2010 Feb; 29(5):752-62. PubMed ID: 19901966
[TBL] [Abstract][Full Text] [Related]
46. Serum osteopontin, an enhancer of tumor metastasis to bone, promotes B16 melanoma cell migration.
Hayashi C; Rittling S; Hayata T; Amagasa T; Denhardt D; Ezura Y; Nakashima K; Noda M
J Cell Biochem; 2007 Jul; 101(4):979-86. PubMed ID: 17390343
[TBL] [Abstract][Full Text] [Related]
47. The functional -443T/C osteopontin promoter polymorphism influences osteopontin gene expression in melanoma cells via binding of c-Myb transcription factor.
Schultz J; Lorenz P; Ibrahim SM; Kundt G; Gross G; Kunz M
Mol Carcinog; 2009 Jan; 48(1):14-23. PubMed ID: 18459127
[TBL] [Abstract][Full Text] [Related]
48. Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells.
Mi Z; Guo H; Wai PY; Gao C; Kuo PC
Carcinogenesis; 2006 Jun; 27(6):1134-45. PubMed ID: 16474180
[TBL] [Abstract][Full Text] [Related]
49. Osteopontin Regulates Hepatitis C Virus (HCV) Replication and Assembly by Interacting with HCV Proteins and Lipid Droplets and by Binding to Receptors αVβ3 and CD44.
Iqbal J; Sarkar-Dutta M; McRae S; Ramachandran A; Kumar B; Waris G
J Virol; 2018 Jul; 92(13):. PubMed ID: 29669827
[TBL] [Abstract][Full Text] [Related]
50. Alpha-V-dependent outside-in signaling is required for the regulation of CD44 surface expression, MMP-2 secretion, and cell migration by osteopontin in human melanoma cells.
Samanna V; Wei H; Ego-Osuala D; Chellaiah MA
Exp Cell Res; 2006 Jul; 312(12):2214-30. PubMed ID: 16631740
[TBL] [Abstract][Full Text] [Related]
51. Osteopontin and the skin: multiple emerging roles in cutaneous biology and pathology.
Buback F; Renkl AC; Schulz G; Weiss JM
Exp Dermatol; 2009 Sep; 18(9):750-9. PubMed ID: 19558497
[TBL] [Abstract][Full Text] [Related]
52. Expression of osteopontin-5 splice variant in the mouse primary and metastatic breast cancer cells.
Kamalabadi-Farahani M; Atashi A; Jabbarpour Z; Aghayan SS
BMC Res Notes; 2022 Sep; 15(1):286. PubMed ID: 36064446
[TBL] [Abstract][Full Text] [Related]
53. Osteopontin-enhanced hepatic metastasis of colorectal cancer cells.
Huang J; Pan C; Hu H; Zheng S; Ding L
PLoS One; 2012; 7(10):e47901. PubMed ID: 23112867
[TBL] [Abstract][Full Text] [Related]
54. Osteopontin is an important mediator of alcoholic liver disease via hepatic stellate cell activation.
Seth D; Duly A; Kuo PC; McCaughan GW; Haber PS
World J Gastroenterol; 2014 Sep; 20(36):13088-104. PubMed ID: 25278703
[TBL] [Abstract][Full Text] [Related]
55. Inhibitory effect of ethanol extract of Ocimum sanctum on osteopontin mediated metastasis of NCI-H460 non-small cell lung cancer cells.
Kwak TK; Sohn EJ; Kim S; Won G; Choi JU; Jeong K; Jeong M; Kwon OS; Kim SH
BMC Complement Altern Med; 2014 Oct; 14():419. PubMed ID: 25345853
[TBL] [Abstract][Full Text] [Related]
56. Osteopontin increases breast cancer cell sensitivity to specific signaling pathway inhibitors in preclinical models.
Mutrie JC; Chambers AF; Tuck AB
Cancer Biol Ther; 2011 Oct; 12(8):680-90. PubMed ID: 21795853
[TBL] [Abstract][Full Text] [Related]
57. Investigation of the Osteopontin isoforms expression in patients with acute myeloid leukemia.
Ferdowsi S; Ghaffari SH; Shiraji ST; Mousavi SA; Mohammadi S
Med Oncol; 2021 Jul; 38(9):102. PubMed ID: 34313836
[TBL] [Abstract][Full Text] [Related]
58. Role of osteopontin in cellular signaling and metastatic phenotype.
El-Tanani MK
Front Biosci; 2008 May; 13():4276-84. PubMed ID: 18508510
[TBL] [Abstract][Full Text] [Related]
59. Mechanism of ketotifen fumarate inhibiting renal calcium oxalate stone formation in SD rats.
Huang Z; Wang G; Yang B; Li P; Yang T; Wu Y; Yang X; Liu J; Li J
Biomed Pharmacother; 2022 Jul; 151():113147. PubMed ID: 35643070
[TBL] [Abstract][Full Text] [Related]
60. Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells.
Philip S; Bulbule A; Kundu GC
J Biol Chem; 2001 Nov; 276(48):44926-35. PubMed ID: 11564733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]